Estimates Revisions Revelation Biosciences, Inc.
Stocks
REVB
US76135L8046
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.160 USD | -1.69% |
|
+16.00% | -63.74% |
| 07-10 | Revelation Biosciences Adopts Stockholder Rights Plan | MT |
| 05-07 | Revelation Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
EBIT
- Stock Market
- Stocks
- REVB Stock
- Consensus Revelation Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
